ENSC
Price
$0.44
Change
-$0.00 (-0.00%)
Updated
Sep 3 closing price
Capitalization
8.56M
73 days until earnings call
Intraday BUY SELL Signals
KAPA
Price
$1.68
Change
+$0.10 (+6.33%)
Updated
Sep 3, 04:59 PM (EDT)
Capitalization
5.65M
Intraday BUY SELL Signals
Interact to see
Advertisement

ENSC vs KAPA

ENSC vs KAPA Comparison Chart in %
loading
loading
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Nektar Therapeutics (NASDAQ:NKTR), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO), Cel-Sci Corp (ASE:CVM).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.34B. The market cap for tickers in the group ranges from 58 to 141.42B. VRTX holds the highest valuation in this group at 141.42B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -3%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 2,267%. QNRX experienced the highest price growth at 64%, while VBIO experienced the biggest fall at -96%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 21%. For the same stocks of the Industry, the average monthly volume growth was 9% and the average quarterly volume growth was 19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 78
Price Growth Rating: 53
SMR Rating: 94
Profit Risk Rating: 92
Seasonality Score: -10 (-100 ... +100)

Market Cap

The average market capitalization across the group is 7.11M. The market cap for tickers in the group ranges from 5.65M to 8.56M. ENSC holds the highest valuation in this group at 8.56M. The lowest valued company is KAPA at 5.65M.

High and low price notable news

The average weekly price growth across all stocks in the group was 5%. For the same group, the average monthly price growth was -6%, and the average quarterly price growth was -41%. ENSC experienced the highest price growth at 10%, while KAPA experienced the biggest fall at -1%.

Volume

The average weekly volume growth across all stocks in the group was 48%. For the same stocks of the group, the average monthly volume growth was 75% and the average quarterly volume growth was 203%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 12
P/E Growth Rating: 84
Price Growth Rating: 66
SMR Rating: 99
Profit Risk Rating: 100
Seasonality Score: -50 (-100 ... +100)
VS
ENSC vs. KAPA commentary
Sep 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENSC is a Hold and KAPA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2026
Stock price -- (ENSC: $0.44 vs. KAPA: $1.67)
Brand notoriety: ENSC and KAPA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENSC: 4% vs. KAPA: 13%
Market capitalization -- ENSC: $8.56M vs. KAPA: $5.65M
ENSC [@Biotechnology] is valued at $8.56M. KAPA’s [@Biotechnology] market capitalization is $5.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $141.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENSC’s FA Score shows that 1 FA rating(s) are green whileKAPA’s FA Score has 1 green FA rating(s).

  • ENSC’s FA Score: 1 green, 4 red.
  • KAPA’s FA Score: 1 green, 4 red.
According to our system of comparison, ENSC is a better buy in the long-term than KAPA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENSC’s TA Score shows that 5 TA indicator(s) are bullish while KAPA’s TA Score has 4 bullish TA indicator(s).

  • ENSC’s TA Score: 5 bullish, 5 bearish.
  • KAPA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ENSC is a better buy in the short-term than KAPA.

Price Growth

ENSC (@Biotechnology) experienced а +10.28% price change this week, while KAPA (@Biotechnology) price change was -1.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.14%. For the same industry, the average monthly price growth was +5.15%, and the average quarterly price growth was +2267.37%.

Reported Earning Dates

ENSC is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-3.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENSC($8.56M) has a higher market cap than KAPA($5.65M). ENSC YTD gains are higher at: -52.174 vs. KAPA (-66.398). KAPA has higher annual earnings (EBITDA): -5.69M vs. ENSC (-11.76M). KAPA has more cash in the bank: 1.27M vs. ENSC (745K). KAPA has less debt than ENSC: KAPA (142K) vs ENSC (246K). ENSC (0) and KAPA (0) have equivalent revenues.
ENSCKAPAENSC / KAPA
Capitalization8.56M5.65M151%
EBITDA-11.76M-5.69M207%
Gain YTD-52.174-66.39879%
P/E Ratio0.02N/A-
Revenue00-
Total Cash745K1.27M59%
Total Debt246K142K173%
FUNDAMENTALS RATINGS
ENSC: Fundamental Ratings
ENSC
OUTLOOK RATING
1..100
96
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
69
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENSCKAPA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ENSC
Daily Signal:
Gain/Loss:
KAPA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGRX0.390.01
+1.64%
Mangoceuticals Inc
WTW342.064.33
+1.28%
Willis Towers Watson Public Limited
PLNT51.50-0.18
-0.35%
Planet Fitness
OBE12.03-0.05
-0.41%
Obsidian Energy Ltd
COOK48.61-2.80
-5.45%
Traeger

ENSC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ENSC has been loosely correlated with SLXN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSC jumps, then SLXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENSC
1D Price
Change %
ENSC100%
-0.63%
SLXN - ENSC
34%
Loosely correlated
+0.11%
NEUP - ENSC
31%
Poorly correlated
+0.27%
RLMD - ENSC
31%
Poorly correlated
-3.74%
FTH - ENSC
31%
Poorly correlated
-0.31%
IBIO - ENSC
29%
Poorly correlated
-0.76%
More

KAPA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KAPA has been loosely correlated with INKT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if KAPA jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAPA
1D Price
Change %
KAPA100%
+5.70%
INKT - KAPA
50%
Loosely correlated
-0.88%
BGMS - KAPA
46%
Loosely correlated
+10.69%
ENSC - KAPA
27%
Poorly correlated
-0.63%
PHIO - KAPA
26%
Poorly correlated
-1.77%
TCRT - KAPA
26%
Poorly correlated
-1.20%
More